Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Bolar exemption
Fordham 32 (Report 1): Patents in Pharma Fordham 32 (Report 1): Patents in Pharma Reviewed by Annsley Merelle Ward on Thursday, April 24, 2025 Rating: 5
Can Unified Patent Court and national laws of infringement diverge? An IPKat dialogue Can Unified Patent Court and national laws of infringement diverge? An IPKat dialogue Reviewed by Darren Smyth on Thursday, January 15, 2015 Rating: 5
More on amendments to Bolar provisions - this time in Ireland More on amendments to Bolar provisions - this time in Ireland Reviewed by Darren Smyth on Monday, August 11, 2014 Rating: 5
An elegant way to have different defences to patent infringement under the UPC? UK IPO may have found one... An elegant way to have different defences to patent infringement under the UPC? UK IPO may have found one... Reviewed by Darren Smyth on Wednesday, May 14, 2014 Rating: 5
Astellas Pharma: your chance to comment Astellas Pharma: your chance to comment Reviewed by Jeremy on Wednesday, February 05, 2014 Rating: 5
Patent infringement, the Bolar exemption and suppliers: questions for the CJEU Patent infringement, the Bolar exemption and suppliers: questions for the CJEU Reviewed by Jeremy on Wednesday, January 15, 2014 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.